In primary prostate cancer, Gains/amplifications in this region associated with Gleason grade, tumour stage, number of positive lymph nodes, bone scan results and as these variables contribute to time to disease-free survival, patients stratified by NAALADL2/TBL1XR1 status also have altered disease-free survival times. Here, NAALADL2 is linked to prostate carcinoma.